Value of blood pool contrast agents in magnetic resonance angiography of the pelvis and lower extremities

被引:40
作者
Saeed, M [1 ]
Wendland, MF [1 ]
Engelbrecht, M [1 ]
Sakuma, H [1 ]
Higgins, CB [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
关键词
magnetic resonance angiography; blood pool MR contrast agents; ultrasmall superparamagnetic iron oxide; peripheral vessels;
D O I
10.1007/s003300050512
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Our objective was: (1) to determine the appropriate dose of new ultrasmall superparamagnetic iron ox ide particles for magnetic resonance angiography (MRA). This agent comprised of a single iron oxide crystal stabilized with a carbohydrate-polyethylene glycol coat (PEG-Ferron/NC 100150 injection); (2) to determine the proper flip angle for PEG-Ferron-enhanced 3 time-of-flight (TOF) MRA sequence, and (3) to compare the enhancement of peripheral vessels following PEG-Ferron and GdDTPA-BMA. MRA parameters were: TR/TE = 50/2.1 ms, NEX = 1, FOV = 30 x 30 x 1.8 cm, and matrix = 256 x 128 x 64. In anesthetized beagle dogs (n=10), the effects of PEG-Ferron and GdDTPA-BMA on regional signal were monitored for 45 min and compared. The lowest dose of PEG-Ferron (0.05 mmol/kg) produced the best enhancement of primary, secondary and tertiary vessels. The flip angle 60 degrees provided better enhancement than 20 degrees on contrast enhanced images, Unlike GdDTPA-BMA, PEG-Ferron allowed prolonged delineation (> 45 min) of the pelvis and lower extremities circulation, PEG-Ferron provided greater Contrast-to-noise ratio CNR (80.2+/-6.2, P<0.05) than GdDTPA-BMA (63.5 +/- 2.5). It may be possible for blood pool contrast-enhanced 3D TOF MRA to provide valuable information for visualization of vascular tree including guiding interventions.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 20 条
[1]  
ADZAMLI K, 1997, P 5 SCI M INT SOC MA, P1573
[2]   IMPROVED MR-ANGIOGRAPHY - MAGNETIZATION-TRANSFER SUPPRESSION WITH VARIABLE FLIP ANGLE EXCITATION AND INCREASED RESOLUTION [J].
ATKINSON, D ;
BRANTZAWADZKI, M ;
GILLAN, G ;
PURDY, D ;
LAUB, G .
RADIOLOGY, 1994, 190 (03) :890-894
[3]  
BLATTER DD, 1993, AM J ROENTGENOL, V161, P1269, DOI 10.2214/ajr.161.6.8249741
[4]   Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body [J].
Bourne, MW ;
Margerun, L ;
Hylton, N ;
Campion, B ;
Lai, JJ ;
Derugin, N ;
Higgins, CB .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1996, 6 (02) :305-310
[5]   RATIONALE AND APPLICATIONS FOR MACROMOLECULAR GD-BASED CONTRAST AGENTS [J].
BRASCH, RC .
MAGNETIC RESONANCE IN MEDICINE, 1991, 22 (02) :282-287
[6]   MR-ANGIOGRAPHY - PRESENT AND FUTURE [J].
EDELMAN, RR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1993, 161 (01) :1-11
[7]   ENHANCEMENT OF MR-ANGIOGRAPHY WITH IRON-OXIDE - PRELIMINARY STUDIES IN WHOLE-BLOOD PHANTOM AND IN ANIMALS [J].
FRANK, H ;
WEISSLEDER, R ;
BRADY, TJ .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 162 (01) :209-213
[8]   PHASE-CONTRAST MR ANGIOGRAPHY WITH REDUCED ACQUISITION TIME - NEW CONCEPTS IN SEQUENCE DESIGN [J].
HAUSMANN, R ;
LEWIN, JS ;
LAUB, G .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1991, 1 (04) :415-422
[9]   DISPLAYS FOR MR ANGIOGRAPHY [J].
LAUB, G .
MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (02) :222-229
[10]   MS-325: A small-molecule vascular imaging agent for magnetic resonance imaging [J].
Lauffer, RB ;
Parmelee, DJ ;
Ouellet, HS ;
Dolan, RP ;
Sajiki, H ;
Scott, DM ;
Bernard, PJ ;
Buchanan, EM ;
Ong, KY ;
Tyeklar, Z ;
Midelfort, KS ;
McMurry, TJ ;
Walovitch, RC .
ACADEMIC RADIOLOGY, 1996, 3 :S356-S358